NCT05889806

AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)

AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens Involved in Diseases and Healthy Populations)

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 10,000 (estimated)
• Sponsor: Audubon Bioscience · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Study purpose: to explore the entire spectrum of proteomic and genomic changes (amongst others) involved in diseases and in healthy/control populations. The Study is designed to discover biomarkers, develop and validate diagnostic assays, instruments and therapeutics as well as other medical research. Specifically, researchers may analyze proteins, RNA, DNA copy number changes, including large and small (1,000-100,000 kb) scale rearrangements, transcription profiles, epigenetic modifications, sequence variation, and sequence in both diseased tissue and case-matched germline DNA from Subjects.

Detailed description

The primary objective of this Study is to collect high-quality tissue, whole teeth, and biofluid Specimens, and associated Clinical Data from consented Subjects. The secondary objective of this Study is to test Specimens and associated Clinical Data to confirm pathology diagnosis and correlation of microscopic evaluation with the provided information, to assess RNA and DNA integrity or degradation, and provide overall quality control evaluations.

Conditions

• Oncology
• Hematologic Malignancy
• Gastro-Intestinal Disorder
• Autoimmune Diseases
• Pregnancy Related
• Infectious Disease
• Cardiovascular Diseases
• Genitourinary Disease
• Renal Disease

Interventions

Type	Name	Description
OTHER	Observational Study Only. NO Intervention.	Observational Study Only. NO Intervention.

Timeline

• Start date: 2023-05-10
• Primary completion: 2043-05-10
• Completion: 2043-06-10
• First posted: 2023-06-05
• Last updated: 2023-06-05

Locations

1 site across 1 country: United States